Advertisement
UK markets open in 4 hours 25 minutes

  • NIKKEI 225

    38,112.19
    -293.47 (-0.76%)
     

  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     

  • CRUDE OIL

    81.09
    -0.84 (-1.03%)
     

  • GOLD FUTURES

    2,298.20
    -4.70 (-0.20%)
     

  • DOW

    37,815.92
    -570.17 (-1.49%)
     

  • Bitcoin GBP

    47,851.67
    -3,185.29 (-6.24%)
     

  • CMC Crypto 200

    1,279.88
    -59.19 (-4.42%)
     

  • NASDAQ Composite

    15,657.82
    -325.26 (-2.04%)
     

  • UK FTSE All Share

    4,430.25
    -4.93 (-0.11%)
     
Stocks:

Trending tickers: Amazon, Tesla, Samsung, Mercedes-Benz, Whitbread

The latest investor updates on stocks that are trending on Tuesday

EU Agency backs new drugs from GSK, Novartis, J&J

Reuters - UK Focus

LONDON, Feb 21 (Reuters) - European regulators said on Friday they had recommended approval of 10 drugs, six of which were for respiratory diseases including GlaxoSmithKline (Other OTC: GLAXF - news) 's Anoro and Laventair and Novartis (Xetra: NOT.DE - news) 's Ulunar Breezhaler.

The European Medicine Agency (EMA) also gave the green light to Vokanamet, a treatment for type 2 diabetes marketed by Johnson & Johnson (NYSE: JNJ - news) .

Recommendations for marketing approval by the EMA's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.